相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia et al.
DIABETES CARE (2020)
C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet
Magdalena M. Bogun et al.
DIABETES CARE (2020)
PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes
Xia Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes
Hossam A. Abdelsamed et al.
NATURE IMMUNOLOGY (2020)
Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells
Daniel Neiman et al.
JCI INSIGHT (2020)
Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes
Natalie M. Edner et al.
NATURE IMMUNOLOGY (2020)
A quantitative measure of treatment response in recent-onset type 1 diabetes
Brian N. Bundy et al.
ENDOCRINOLOGY DIABETES & METABOLISM (2020)
Type 1 diabetes progression is associated with loss of CD3+CD56+ regulatory T cells that control CD8+ T-cell effector functions
Giuseppe Terrazzano et al.
NATURE METABOLISM (2020)
Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes
Peter S. Linsley et al.
GENES AND IMMUNITY (2019)
Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D Progression
Tania Habib et al.
DIABETES (2019)
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Laura M. McLane et al.
Annual Review of Immunology (2019)
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
Michael J. Haller et al.
DIABETES (2019)
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances
Simi Ahmed et al.
DIABETES (2019)
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes
Hugo Barcenilla et al.
FRONTIERS IN IMMUNOLOGY (2019)
Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset
John Virostko et al.
DIABETES CARE (2019)
Cell type-specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes
Matthew J. Dufort et al.
JCI INSIGHT (2019)
B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes
Peter S. Linsley et al.
JCI INSIGHT (2019)
Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes
Polly J. Bingley et al.
DIABETES CARE (2018)
Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes
Lorraine Yeo et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes
Susanne M. Cabrera et al.
DIABETOLOGIA (2018)
β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis
Carmella Evans-Molina et al.
JCI INSIGHT (2018)
Circulating CXCR5+PD-1+ICOS+ Follicular T Helper Cells Are Increased Close to the Diagnosis of Type 1 Diabetes in Children With Multiple Autoantibodies
Tyyne Viisanen et al.
DIABETES (2017)
Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes A Randomized Clinical Trial
C. Greenbaum et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Measurement of Pro-Islet Amyloid Polypeptide (1-48) in Diabetes and Islet Transplants
Jaques A. Courtade et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Assessment of β Cell Mass and Function by AIRmax and Intravenous Glucose in High-Risk Subjects for Type 1 Diabetes
Wei Hao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes
Karen Cerosaletti et al.
JOURNAL OF IMMUNOLOGY (2017)
T Cell Receptor Profiling in Type 1 Diabetes
Laura M. Jacobsen et al.
CURRENT DIABETES REPORTS (2017)
Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes
Emily K. Sims et al.
DIABETES CARE (2016)
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial
Stephen E. Gitelman et al.
DIABETOLOGIA (2016)
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Roni Lehmann-Werman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes
S. Alice Long et al.
SCIENCE IMMUNOLOGY (2016)
Abnormalities of the Exocrine Pancreas in Type 1 Diabetes
Martha Campbell-Thompson et al.
CURRENT DIABETES REPORTS (2015)
Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report
Diane K. Wherrett et al.
DIABETES CARE (2015)
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Mark R. Rigby et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline
Tihamer Orban et al.
DIABETES (2014)
Treat-to-target trials: uses, interpretation and review of concepts
A. J. Garber
DIABETES OBESITY & METABOLISM (2014)
Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants
Jay M. Sosenko et al.
DIABETES (2013)
Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
Kevan C. Herold et al.
DIABETES (2013)
Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
Carla J. Greenbaum et al.
DIABETES (2012)
Fall in C-Peptide During First 2 Years From Diagnosis Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes Trial Net Data
Carla J. Greenbaum et al.
DIABETES (2012)
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Tihamer Orban et al.
LANCET (2011)
Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+ CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects
S. Alice Long et al.
DIABETES (2010)
Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys
Y. Saisho et al.
DIABETOLOGIA (2010)
Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients
E. Vandemeulebroucke et al.
DIABETOLOGIA (2010)
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells
Anya Schneider et al.
JOURNAL OF IMMUNOLOGY (2008)
Relationship between β-cell mass and fasting blood glucose concentration in humans
RA Ritzel et al.
DIABETES CARE (2006)
Type 1 diabetes manifested solely by 2-h oral glucose tolerance test criteria
CJ Greenbaum et al.
DIABETES (2001)
分享论文
